Literature DB >> 15590388

Infectious toxicity using alemtuzumab.

Annamaria Nosari, Marco Montillo, Enrica Morra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590388

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

Review 1.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

Review 2.  Viral infection after renal transplantation: surveillance and management.

Authors:  Blair C Weikert; Emily A Blumberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

Review 3.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

Review 4.  Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.

Authors:  Xuqin Jiang; Xiaodong Mei; Di Feng; Xiaojing Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 5.  Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation.

Authors:  Babina Gosangi; Matthew Davids; Bhanusupriya Somarouthu; Francesco Alessandrino; Angela Giardino; Nikhil Ramaiya; Katherine Krajewski
Journal:  Cancer Imaging       Date:  2018-04-18       Impact factor: 3.909

6.  Infectious complications in chronic lymphocytic leukemia.

Authors:  Annamaria Nosari
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-05       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.